Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,082Revenue $M160Net Margin (%)-13.5Z-Score42.0
Enterprise Value $M3,026EPS $-0.4Operating Margin %-13.1F-Score6
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-13.5Higher ROA y-yY
Price/Book31.210-y EBITDA Growth Rate %-21.7Quick Ratio2.6Cash flow > EarningsY
Price/Sales15.15-y EBITDA Growth Rate %-21.0Current Ratio3.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-19.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-27.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M74.9ROI % (ttm)-53.5Gross Margin Increase y-yY

Gurus Latest Trades with DXCM

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
DXCMJoel Greenblatt 2014-06-30 Buy $29.68 - $41.95
$ 41.2317%New holding, 8033 sh.8,033
DXCMGeorge Soros 2013-09-30 Sold Out -0.02%$21.78 - $29.19
$ 41.2363%Sold Out0
DXCMGeorge Soros 2013-03-31 Buy 0.02%$13.59 - $17.05
$ 41.23171%New holding, 100000 sh.100,000
DXCMRon Baron 2012-12-31 Buy 0.11%$12.3 - $14.95
$ 41.23208%New holding, 1250000 sh.1,250,000
DXCMGeorge Soros 2011-09-30 Sold Out -0.0025%$10.3 - $15.66
$ 41.23218%Sold Out0
DXCMGeorge Soros 2011-06-30 Buy $13.05 - $16.72
$ 41.23170%New holding, 12500 sh.12,500
DXCMGeorge Soros 2011-03-31 Sold Out $13.3 - $15.79
$ 41.23186%Sold Out0
DXCMMario Gabelli 2011-03-31 Reduce-0.01%$13.3 - $15.79
$ 41.23186%Reduce -55.46%77,500
DXCMGeorge Soros 2010-09-30 Reduce$10.76 - $14.06
$ 41.23235%Reduce -43.37%14,100
DXCMGeorge Soros 2010-06-30 Buy 0.01%$9.22 - $11.65
$ 41.23293%New holding, 24900 sh.24,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DXCM is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DXCM Joel Greenblatt 2014-06-308,0330.010New Buy
DXCM Ron Baron 2014-06-301,348,5721.80.21-0.41%
DXCM Mario Gabelli 2014-06-3070,5000.090.02-0.7%
Premium Most recent portfolio changes are included for Premium Members only!

DXCM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Balo Andrew KSVP, Regulatory and Clinical 2014-09-11Sell10,000$42.971.21view
VALDES JORGE ACTO 2014-09-08Sell16,000$42.981.19view
KAHN BARBARADirector 2014-08-28Sell4,000$44.52-2.31view
LORD JONATHAN T MDDirector 2014-08-26Sell20,000$45.56-4.54view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2014-08-26Sell30,000$44.56-2.4view
MOY JEFFREYSVP, Operations 2014-08-26Sell16,663$45.3-4view
GREGG TERRANCE HCEO, 10% Owner 2014-08-26Sell5,000$46.05-5.56view
DOUBLEDAY RICHARDSr. VP. Worldwide Sales 2014-08-25Sell4,000$44.35-1.94view
Balo Andrew KSVP, Regulatory and Clinical 2014-08-25Sell10,000$44.12-1.43view
GREGG TERRANCE HCEO, 10% Owner 2014-08-22Sell13,607$44.46-2.18view

Press Releases about DXCM :

    Quarterly/Annual Reports about DXCM:

    News about DXCM:

    Articles On GuruFocus.com
    Top Insider Sells Highlight: Dexcom Inc. Aug 22 2014 
    DexCom Reports $1 Million Insider Buy Mar 12 2013 
    DexCom Inc. Reports Operating Results (10-Q) Aug 03 2010 
    DexCom Inc. Reports Operating Results (10-Q) May 05 2010 
    DexCom Inc. Reports Operating Results (10-Q) Nov 04 2009 
    DexCom Inc. Reports Operating Results (10-Q) Aug 03 2009 
    DexCom Inc. Reports Second Quarter 2009 Financial Results Aug 03 2009 
    DexCom Inc. (DXCM) CEO Terrance H Gregg buys 20,000 Shares May 14 2009 
    DexCom Inc. Reports Operating Results (10-Q) May 06 2009 
    DexCom Inc. (DXCM) CEO Terrance H Gregg buys 50,000 Shares Mar 17 2009 

    More From Other Websites
    3 Stocks Dragging The Health Services Industry Downward Sep 03 2014
    [video] A sensor to swallow with your medicine Aug 25 2014
    Top Insider Sells Highlight: Dexcom Inc. Aug 22 2014
    DexCom Continues to Gain; Enters Data Integration Deal Aug 14 2014
    DEXCOM INC Financials Aug 13 2014
    DexCom Sees Narrower Q2 Loss; Revenues Top Estimates Aug 07 2014
    Trade-Ideas: DexCom (DXCM) Is Today's "Barbarian At The Gate" Stock Aug 07 2014
    Dexcom Announces Data Integration Relationship with Asante Solutions, Makers of the Snap™ Insulin... Aug 07 2014
    DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 06 2014
    DexCom, Inc. Reports Second Quarter 2014 Financial Results Aug 06 2014
    Q2 2014 DEXCOM INC Earnings Release - After Market Close Aug 06 2014
    Insulet and Dexcom Agree to Develop a CGM-Integrated Personal Diabetes Manager Aug 05 2014
    Jay D. Miller, the President and CEO of IMRIS Inc. (IMRS), Interviews with The Wall Street... Aug 01 2014
    DexCom to Present at Canaccord Genuity 34th Annual Growth Conference Jul 31 2014
    DexCom Schedules Second Quarter 2014 Earnings Release and Conference Call for August 6, 2014 at 4:30... Jul 23 2014
    5 New Medical Technologies For Diabetics Jul 18 2014
    DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 07 2014
    DexCom Collaborates with Insulet Corporation Jun 16 2014
    Freedom for Diabetics as Bionic Pancreas Passes Testing Jun 15 2014
    Diabetics Get Freedom in Bionic Pancreas Real-World Trial Jun 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial